Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

NCT00003080 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: endocrine-modulating drug therapy
DRUG: melphalan
DRUG: mitoxantrone hydrochloride
DRUG: tamoxifen citrate
DRUG: thiotepa
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]